| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 09/21/2011 | EP2365810A2 Phosphatidylinositol-3-kinase p110 delta-targeted drugs in the treatment of cns disorders |
| 09/21/2011 | EP2365809A1 Pyrazinopyrazines and derivatives as kinase inhibitors |
| 09/21/2011 | EP2365808A1 Combination of morphinan compounds and antidepressant for the treatment of pseudobulbar affect, neurological diseases, intractable and chronic pain and brain injury |
| 09/21/2011 | EP2365807A1 Oral composition |
| 09/21/2011 | EP2365806A1 Ophthalmic solutions, including contact lens care solutions and eye drops comprising carnosine, preferably in combination with dexpanthenol and/or hyaluronic acid |
| 09/21/2011 | EP2365805A1 Method of treating sleep disorders using eplivanserin |
| 09/21/2011 | EP2365804A2 Modification of amyloid-beta load in non-brain tissue |
| 09/21/2011 | EP2365802A2 Inhibition of mammalian target of rapamycin |
| 09/21/2011 | EP2365800A2 Ulipristal acetate tablets |
| 09/21/2011 | EP2365799A1 Directly compressible high functionality granular dibasic calcium phosphate based co-processed excipient |
| 09/21/2011 | EP2365798A2 Wet granulation of tenofovir, emtricitabine and efavirenz |
| 09/21/2011 | EP2365760A1 Novel compound containing vanillin and ethylvanillin, and preparation and applications thereof |
| 09/21/2011 | EP2365759A1 Antioxidant-containing food composition for use in inhibiting histamine pathways in companion animals |
| 09/21/2011 | EP2365752A1 Cyclopropane amides and analogs exhibiting anti-cancer and anti-proliferative activities |
| 09/21/2011 | EP2365751A1 Isoxazole derivatives for use as fungicides |
| 09/21/2011 | EP2365749A1 Quinolone neuropeptide s receptor antagonists |
| 09/21/2011 | EP2365748A1 Imidazoisoindole neuropeptide s receptor antagonists |
| 09/21/2011 | EP2365747A1 Methods for treating gastrointestinal diseases |
| 09/21/2011 | EP2351764A8 Trehalose compound, method for producing same, and pharmaceutical product containing the compound |
| 09/21/2011 | EP2351742A8 Indazole derivative |
| 09/21/2011 | EP2278956B1 Antiviral formulation |
| 09/21/2011 | EP2260042B1 Substituted spirocyclic cyclohexane derivatives |
| 09/21/2011 | EP2238116B1 Novel imidazolinylmethyl aryl sulfonamides |
| 09/21/2011 | EP2219642B1 Silibinin component for the treatment of hepatitis |
| 09/21/2011 | EP2215082B1 Phthalazine and pyrido[3,4-d]pyridazine compounds as h1 receptor antagonists |
| 09/21/2011 | EP2212283B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2212282B1 Substituted n-phenyl-bipyrrolidine carboxamides and therapeutic use thereof |
| 09/21/2011 | EP2170819B1 Prostaglandin pharmaceutical compositions |
| 09/21/2011 | EP2155683B8 Pyridone derivatives as p38a mapk inhibitors |
| 09/21/2011 | EP2144604B1 Methods for the treatment of chronic viral hepatitis C using RO 113-0830 |
| 09/21/2011 | EP2134346B1 Inhibitors of janus kinases and/or 3-phosphoinositide-dependent protein kinase-1 |
| 09/21/2011 | EP2103610B1 Salts of imidazol-5-carboxylic acid derivatives, preparation methods and use thereof |
| 09/21/2011 | EP2045258B1 3'-ethynylcytidine derivative |
| 09/21/2011 | EP2029595B1 Novel 1,4-diaza-bicyclo[3.2.2]nonyl pyrimidinyl derivative and its medical use |
| 09/21/2011 | EP2024354B1 1- [ (4- [benzoyl (methyl) amino]-3- (phenyl) butyl]azetidine derivatives for the treatment of gastrointestinal disorders 1 |
| 09/21/2011 | EP1988777B1 Pyrazoles for the treatment of obesity and other cns disorders |
| 09/21/2011 | EP1971338B8 Combination of zd6474 and pemetrexed |
| 09/21/2011 | EP1966202B1 Heteroaryl substituted pyrrolo[2,3-b]pyridines and pyrrolo[2,3-b]pyrimidines as janus kinase inhibitors |
| 09/21/2011 | EP1965864B1 Composition of inverse emulsion type comprising ivermectin, and uses thereof in cosmetics and dermatology |
| 09/21/2011 | EP1945630B1 Pyrazine derivatives as sodium channel modulators for the treatment of pain |
| 09/21/2011 | EP1913943B1 Prophylactic or therapeutic composition for hemoglobinuria or myoglobinuria |
| 09/21/2011 | EP1896424B1 MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kB ACTIVITY AND USE THEREOF |
| 09/21/2011 | EP1873204B1 Polymeric pharmaceutical agent for treatment of cancer and process for production of the same |
| 09/21/2011 | EP1872796B1 Transdermal preparation for external use containing nonsteroidal antiinflammatory/analgesic agent |
| 09/21/2011 | EP1843771B1 Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity |
| 09/21/2011 | EP1773854B1 Azasugar derivatives, heparanase inhibitors, method for preparing same, compositions containing same, use thereof |
| 09/21/2011 | EP1771413B1 Benzofuran derivatives as selective androgen receptor modulators (sarms) |
| 09/21/2011 | EP1751171B1 Novel galactoside inhibitors of galectins |
| 09/21/2011 | EP1737979B9 Method for diagnosing non-small cell lung cancer |
| 09/21/2011 | EP1720551B9 Alkaloid formulations |
| 09/21/2011 | EP1697005B1 Combination of flupirtine and tramadol |
| 09/21/2011 | EP1675860B1 Imidazo[1,5-a]pyrazines as tyrosine kinase inhibitors |
| 09/21/2011 | EP1675835B1 Methods of preparation of dehydro-diketopiperazines in liquid phase or on solid supported phase |
| 09/21/2011 | EP1633345B1 Compounds inhibiting the binding of sap for treating osteoarthritis |
| 09/21/2011 | EP1616577B1 2-chloro-6,7-dimethoxy-N-5 [5-(1)H- indazolyl]quinazoline-4-amine, N-(1-benzyl-4-piperidinyl)-1H-indazole-5-amine dihydrochloride, 4-[2-(2,3,4,5,6-pentafluorophenyl)acryloyl]cinnamic acid and fasudil hydrochloride for use in repairing corneal perception. |
| 09/21/2011 | EP1613679B1 Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| 09/21/2011 | EP1572240B1 Compositions, methods, and kits useful for the alleviation of gastrointestinal side effects of lipase inhibitors |
| 09/21/2011 | EP1560588B1 Treatment for traumatic synovitis and damaged articular cartilage |
| 09/21/2011 | EP1553927B9 Gel-stabilized nanoparticulate active agent compositions |
| 09/21/2011 | EP1531873B1 Agent delivery particle |
| 09/21/2011 | EP1519956B1 Epha2 monoclonal antibodies and methods of use thereof |
| 09/21/2011 | EP1505963B9 Hepatitis c virus inhibitors |
| 09/21/2011 | EP1487428B1 Amino-substituted (e)-2,6-dialkoxystyryl 4-substituted benzylsulfones for treating proliferative disorders |
| 09/21/2011 | EP1436298B1 Himbacine analogues as thrombin receptor antagonists |
| 09/21/2011 | EP1385993B8 Method of detecting and treating tuberous sclerosis complex associated disorders |
| 09/21/2011 | EP1341546B1 Kyberdrug as autovaccines with immune-regulating effects |
| 09/21/2011 | EP1296998B1 Hcv variants |
| 09/21/2011 | EP1274464B1 Compositions and methods for regulated protein expression in gut |
| 09/21/2011 | EP1200385B2 Process for the preparation of crystals of the sodium salt of pravastatin |
| 09/21/2011 | EP1068357B1 Therapeutic and diagnostic applications based on the role of the cxcr-4 gene in tumorigenesis |
| 09/21/2011 | EP1003728B1 2-(3-(4-(2-t-Butyl-6-trifluoromethylpyrimidin-4-yl)piperazin-1-yl)propylmercapto)pyrimidin-4-ol-fumarate |
| 09/21/2011 | EP0954303B1 Methods of treating mental diseases, inflammation and pain |
| 09/21/2011 | CN201978189U 护眼贴 Eye stickers |
| 09/21/2011 | CN1919252B Medicine for treating cardiovascular and cerebrovascular disease |
| 09/21/2011 | CN1897924B Drug coating providing high drug loading and methods for providing same |
| 09/21/2011 | CN1894278B Akt activity specifically inhibiting polypeptide |
| 09/21/2011 | CN1894217B Substituted dibenzo-azepine and benzo-diazepine derivatives useful as gamma-secretase inhibitors |
| 09/21/2011 | CN1880294B Polymorphic forms of dexketoprofen trometamol, preparation and pharmaceutical compositions thereof |
| 09/21/2011 | CN1879628B An in-vitro trichomonas vaginalis treating vaginal suppository and preparation method thereof |
| 09/21/2011 | CN1864434B Wireless microphone communication system |
| 09/21/2011 | CN1761467B Use of pyridin-2-ylmethylamine derivatives for the production of a medicament for the treatment of chronic pain symptoms of neuropathological or psychogenic origin |
| 09/21/2011 | CN1723984B Medicine for inducing cells to die, and its application |
| 09/21/2011 | CN1718735B Production of polyglutamic acid using na bean bacillus solid fermentation and its product application |
| 09/21/2011 | CN1711095B Composition for restoring damaged skin |
| 09/21/2011 | CN1697651B 1-phenyl-2-dimethylaminomethyl cyclohexane compounds and therapies for depressive symptoms, pain and incontinence |
| 09/21/2011 | CN1548413B Beta-diketoacid as dimer compound and its prepn and use |
| 09/21/2011 | CN102197038A Substituted tricyclic acid derivatives as S1P1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
| 09/21/2011 | CN102197037A Morphinan compounds |
| 09/21/2011 | CN102197036A New benzofurans suitable as precursors to compounds that are useful for imaging amyloid deposits |
| 09/21/2011 | CN102197035A Novel crystalline form and processes for its preparation |
| 09/21/2011 | CN102197034A Novel polymorphs of sunitinib and processes for their preparation |
| 09/21/2011 | CN102197033A Pyrrole compounds |
| 09/21/2011 | CN102197032A Heterocyclic PIM-kinase inhibitors |
| 09/21/2011 | CN102197031A Substituted 5-aminopyrazoles and use thereof |
| 09/21/2011 | CN102197030A Rotaxane compound and antitumor agent |
| 09/21/2011 | CN102197029A Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine |
| 09/21/2011 | CN102197028A Piperidine derivative, piperazine derivative and agent for treatment of disease involving central nervous system disorders |
| 09/21/2011 | CN102197023A Compounds for treating ophthalmic diseases and disorders |
| 09/21/2011 | CN102197022A Alkyl sulfosuccinate mixtures, and use thereof |
| 09/21/2011 | CN102197019A Thyroid receptor ligands |